1. High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
   Lin Fu et al, 2017, Cancer Science CrossRef
2. Delivering miRNA modulators for cancer treatment
   Marilene Estanqueiro et al, 2018, Drug Targeting and Stimuli Sensitive Drug Delivery Systems CrossRef
3. The expression and role of miR-181a in multiple myeloma
   Ruili Yuan et al, 2018, Medicine CrossRef
4. PPFIA1-targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration
   Rui Su et al, 2023, Molecular Therapy - Nucleic Acids CrossRef
5. Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-κB signalling pathway and inducing apoptosis
   Lili Liu et al, 2017, Experimental and Therapeutic Medicine CrossRef
6. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms
   Cornelia Braicu et al, 2019, Molecular Aspects of Medicine CrossRef
7. miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 + cells partially via SERPINE1
   Xiuyan Zhang et al, 2024, Cellular and Molecular Life Sciences CrossRef
8. Effects and Mechanism of Imatinib in Inhibiting Colon Cancer Cell Proliferation
   Lv Samei et al, 2016, Medical Science Monitor CrossRef
9. Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels
   Manvi Bansal et al, 2024, Medical Oncology CrossRef
10. MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses
    Mahdiyar Iravani Saadi et al, 2021, VirusDisease CrossRef
11. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
    Alessia Indrieri et al, 2020, International Journal of Molecular Sciences CrossRef
12. Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells
    Priyanka Singh et al, 2022, Current Issues in Molecular Biology CrossRef
13. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia
    Anna Chorzalska et al, 2017, Stem Cells and Development CrossRef
14. Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases
    Ji Zhang et al, 2019, Future Oncology CrossRef